Gautam Borthakur

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 130

Top Venues

American journal of hematology

Leukemia & lymphoma

Blood cancer journal

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

Branko Cuglievan, Hagop M Kantarjian, Jeffrey E Rubnitz, Todd M Cooper, C Michel Zwaan, Jessica A Pollard, Courtney D D DiNardo, Tapan Mahendra Kadia, Erin M Guest, Nicholas James Short, David C McCall, Naval G Daver, Cesar Nunez, Fadi G Haddad, Miriam B Garcia, Kapil N Bhalla, Abhishek Maiti, Samanta Catueno, Warren C Fiskus, Bing Z Carter, Amber Gibson, Michael Roth, Sajad Khazal, Priti Tewari, Hussein A Abbas, Wallace Bourgeois, Michael Andreeff, Neerav N Shukla, Danh D Truong, Jeremy Connors, Joseph A Ludwig, Janine Stutterheim, Elisabeth Salzer, Kristian L Juul-Dam, Koiji Sasaki, Kris M Mahadeo, Sarah K Tasian, Gautam Borthakur, Samantha Dickson, Nitin Jain, Elias J Jabbour, Soheil Meshinchi, Guillermo Garcia Manero, Farhad Ravandi, Eytan M Stein, E Anders Kolb, Ghayas C Issa
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. Leukemia (2024)
Fady Gh Haddad, Koiji Sasaki, Jayastu Senapati, Lianchun Xiao, Grace S Hwang, Tareq Abuasab, Sangeetha Venugopal, Daniel Rivera, Alexandre Bazinet, Rodrick Babakhanlou, Kunhwa Kim, Faustine Ong, Sai Desikan, Naveen Pemmaraju, Sanam Loghavi, Gautam Borthakur, Courtney DiNardo, Hussein A Abbas, Nicholas James Short, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis. JCO oncology practice (2024)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances 8 (4) (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology 99 (7) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia 38 (5) (2024)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances 8 (4) (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Wei-Ying Jen, Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D D DiNardo, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Gautam Borthakur, Farhad Ravandi, Naval G Daver
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease. British journal of haematology 205 (1) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Wei-Ying Jen, Elias J Jabbour, Nicholas James Short, Ghayas C Issa, Fady Gh Haddad, Nitin Jain, Naveen Pemmaraju, Naval G Daver, Lucia Masarova, Gautam Borthakur, Kelly Sharon Chien, Rebecca Garris, Hagop M Kantarjian
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. American journal of hematology (2024)
Wei-Ying Jen, Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D D DiNardo, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Gautam Borthakur, Farhad Ravandi, Naval G Daver
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease. British journal of haematology (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology 99 (7) (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Hagop M Kantarjian, Gautam Borthakur, Naval G Daver, Courtney D D DiNardo, Ghayas C Issa, Elias J Jabbour, Tapan Mahendra Kadia, Koiji Sasaki, Nicholas James Short, Musa Ylimaz, Farhad Ravandi
Current status and research directions in acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Wei-Ying Jen, Koiji Sasaki, Sanam Loghavi, Sa A Wang, Wei Qiao, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Naval G Daver, Courtney D D DiNardo
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British journal of haematology 204 (6) (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia (2024)
Courtney D D DiNardo, Divij Verma, Natalia Baran, Tushar D Bhagat, Anna Skwarska, Alessia Lodi, Kapil Saxena, Tianyu Cai, Xiaoping Su, Veronica A Guerra, Gowri Poigaialwar, Vinitha M Kuruvilla, Sergej Konoplev, Shanisha Gordon-Mitchell, Kith Pradhan, Srinivas Aluri, G Lavender Hackman, Sovira Chaudhry, Meghan E Collins, Shannon R Sweeney, Jonathan Busquets, Atul Singh Rathore, Qing Deng, Michael R Green, Steven Grant, Susan Demo, Gaurav S Choudhary, Srabani Sahu, Beamon Agarwal, Mason Spodek, Victor Thiruthuvanathan, Britta Will, Ulrich Steidl, George D Tippett, Jan Burger, Gautam Borthakur, Elias J Jabbour, Naveen Pemmaraju, Tapan Mahendra Kadia, Steven Mitchell Kornblau, Naval G Daver, Kiran Naqvi, Nicholas J Short, Guillermo Garcia Manero, Stefano Tiziani, Amit K Verma, Marina Y Konopleva
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses. Nature cancer (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Wei-Ying Jen, Koiji Sasaki, Sanam Loghavi, Sa A Wang, Wei Qiao, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Naval G Daver, Courtney D D DiNardo
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British journal of haematology (2024)
Tapan Mahendra Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval G Daver, Elias J Jabbour, Courtney D D DiNardo, Naveen Pemmaraju, Nitin Jain, Alessandra Ferrajoli, Musa Ylimaz, Prithviraj Bose, Rebecca S Slack Tidwell, Kayleigh R Marx, Caitlin R Rausch, Rashmi Kanagal-Shamana, Sa A Wang, Rabiul Islam, Richard Champlin, Elizabeth Shpall, Marina Y Konopleva, Guillermo Garcia Manero, Hagop M Kantarjian
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma 64 (3) (2023)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Ziyi Li, Danielle Hammond, Kelly Sharon Chien, Juan Jose Rodriguez-Sevilla, Koiji Sasaki, Elias Jabbour, Courtney DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop Kantarjian, Guillermo Garcia Manero
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia. British journal of haematology (2023)
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Yawa Duose, Rebecca S Slack Tidwell, Nicholas James Short, Gautam Borthakur, Tapan Mahendra Kadia, Lucia Masarova, George D Tippett, Prithviraj Bose, Elias J Jabbour, Farhad Ravandi, Naval G Daver, Guillermo Garcia Manero, Hagop M Kantarjian, Jacqueline S Garcia, Paresh Vyas, Koichi Takahashi, Marina Y Konopleva, Courtney D D DiNardo
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies. Blood cancer discovery (2023)
Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan Mahendra Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas James Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A Lachowiez, Abhishek Maiti, Guillermo Garcia Manero, Elias J Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R Pierce, Hagop M Kantarjian, Courtney D D DiNardo
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents. Blood cancer journal 13 (1) (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Maria Siddiqui, Gautam Borthakur
What value do cell cycle inhibitors have in the treatment of myelodysplastic syndrome? Expert opinion on pharmacotherapy (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Seemana Bhattacharya, Sujan Piya, Huaxian Ma, Priyanka Sharma, Qi Zhang, Natalia Baran, Vivian R Ruvolo, Teresa McQueen, Richard Eric Davis, Rasoul Pourebrahim, Marina Y Konopleva, Hagop M Kantarjian, Nicholas D P Cosford, Michael Andreeff, Gautam Borthakur
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) overcomes adaptive drug resistance in acute myelogenous leukemia. Molecular cancer research : MCR (2023)
Guillermo Montalban Bravo, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Farhad Ravandi, Kelly Sharon Chien, Naveen Pemmaraju, Danielle Hammond, Xiao Qin Dong, Xuelin Huang, Heather Schneider, Rosmy John, Rashmi Kanagal-Shamana, Sanam Loghavi, Hagop Kantarjian, Guillermo Garcia Manero
Phase 1/2 study of CPX-351 for patients with Int-2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents. British journal of haematology (2023)
Samuel Urrutia, Ziyi Li, Emmanuel Almanza, Alex Bataller, Rashmi Kanagal-Shamana, Jayastu Senapati, Koiji Sasaki, Kelly Sharon Chien, Guillermo Montalban-Bravo, Courtney D D DiNardo, Gautam Borthakur, Carlos Bueso-Ramos, Sherry Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations. Leukemia (2023)
Alexandre Bazinet, Hagop M Kantarjian, Naszrin Arani, Uday Popat, Alex Bataller, Koiji Sasaki, Courtney D D DiNardo, Naval G Daver, Musa Ylimaz, Hussein A Abbas, Nicholas James Short, Ghayas C Issa, Elias J Jabbour, Sherry A Pierce, Julianne Chen, Ricky Garcia, Marina Konopleva, Guillermo Garcia Manero, Amin Alousi, Elizabeth J Shpall, Richard E Champlin, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation. American journal of hematology (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D D DiNardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Urrutia Argueta, Kelly Sharon Chien, Ziyi Li, Alex Bataller, Emmanuel Almanza, Koiji Sasaki, Guillermo Montalban Bravo, Nicholas James Short, Elias J Jabbour, Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Yesid Alvarado, Naval G Daver, Rashmi Kanagal-Shamana, Carlos Bueso-Ramos, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure. American journal of hematology (2023)
Sai Prasad Desikan, Jayastu Senapati, Elias Jabbour, Tareq Abuasab, Nicholas Short, Guillin Tang, Sa Wang, Partow Kebriaei, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Kathryn Roberts, Charles Mullighan, Marina Y Konopleva, Hagop M Kantarjian, Nitin Jain
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. American journal of hematology (2023)
Wei-Ying Jen, Koiji Sasaki, Caitlin R Rausch, Courtney D D DiNardo, Tapan Mahendra Kadia, Musa Ylimaz, Gautam Borthakur, Yesid Alvarado, David McCue, Deborah Mccue, Hagop M Kantarjian, Farhad Ravandi
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leukemia & lymphoma (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma (2023)
Marina Konopleva, Courtney D D DiNardo, Tushar Bhagat, Natalia Baran, Alessia Lodi, Kapil Saxena, Tianyu Cai, Xiaoping Su, Anna Skwarska, Veronica Guerra, Vinitha Kuruvilla, Sergej Konoplev, Shanisha Gordon-Mitchell, Kith Pradhan, Srinivas Aluri, Meghan E Collins, Shannon Sweeney, Jonathan Busquet, Atul Rathore, Qing Deng, Michael R Green, Steven Grant, Susan Demo, Gaurav Choudhary, Srabani Sahu, Beamon Agarwal, Mason Spodek, Victor Thiruthuvanathan, Britta Will, Ulrich Steidl, George Tippett, Jan Burger, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Tapan Kadia, Steven Mitchell Kornblau, Naval G Daver, Kiran Naqvi, Nicholas Short, Guillermo Garcia Manero, Stefano Tiziani, Amit Verma
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses. Research square (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Anudishi Tyagi, Appalaraju Jaggupilli, Stanley Ly, Bin Yuan, Fouad El-Dana, Venkatesh L Hegde, Vivek Anand, Bijender Kumar, Mamta Puppala, Zheng Yin, Stephen T C Wong, Alexis Mollard, Hariprasad Vankayalapati, Jason M Foulks, Steven L Warner, Naval G Daver, Gautam Borthakur, Venkata Lokesh Battula
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax. Leukemia (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma 64 (3) (2023)
Christine E Birdwell, Warren C Fiskus, Tapan Mahendra Kadia, Christopher P Mill, Koiji Sasaki, Naval G Daver, Courtney D D DiNardo, Naveen Pemmaraju, Gautam Borthakur, John A Davis, Kaberi Das, Sunil Sharma, Stephen Horrigan, Xinjia Ruan, Xiaoping Su, Joseph D Khoury, Hagop Kantarjian, Kapil N Bhalla
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression. Leukemia (2023)
Sai Prasad Desikan, Jayastu Senapati, Elias J Jabbour, Tareq Abuasab, Nicholas James Short, Guillin Tang, Sa Wang, Partow Kebriaei, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Kathryn Roberts, Charles G Mullighan, Marina Y Konopleva, Hagop M Kantarjian, Nitin Jain
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. American journal of hematology (2023)
Marina Konopleva, Courtney D D DiNardo, Tushar Bhagat, Natalia Baran, Alessia Lodi, Kapil Saxena, Tianyu Cai, Xiaoping Su, Anna Skwarska, Veronica Guerra, Vinitha Kuruvilla, Sergej Konoplev, Shanisha Gordon-Mitchell, Kith Pradhan, Srinivas Aluri, Meghan E Collins, Shannon Sweeney, Jonathan Busquet, Atul Rathore, Qing Deng, Michael R Green, Steven Grant, Susan Demo, Gaurav Choudhary, Srabani Sahu, Beamon Agarwal, Mason Spodek, Victor Thiruthuvanathan, Britta Will, Ulrich Steidl, George Tippett, Jan Burger, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Tapan Kadia, Steven Mitchell Kornblau, Naval G Daver, Kiran Naqvi, Nicholas Short, Guillermo Garcia Manero, Stefano Tiziani, Amit Verma
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses. Research square (2023)
Alex Bataller, Sanam Loghavi, Yoheved Gerstein, Alexandre Bazinet, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Guillermo Montalban Bravo, Gautam Borthakur, Nicholas James Short, Ghayas C Issa, Tapan Mahendra Kadia, Naval G Daver, Guillin Tang, Andres Quesada, Keyur P Patel, Farhad Ravandi, Warren Fiskus, Cristopher P Mill, Hagop M Kantarjian, Kapil N Bhalla, Guillermo Garcia Manero, Betul Oran, Courtney D D DiNardo
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. American journal of hematology (2023)
Jayastu Senapati, Elias J Jabbour, Marina Y Konopleva, Nicholas James Short, Guillin Tang, Naval G Daver, Partow Kebriaei, Tapan Mahendra Kadia, Naveen Pemmaraju, Koichi Takahashi, Courtney D D DiNardo, Koiji Sasaki, Gautam Borthakur, Beenu Thakral, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Farhad Ravandi, Kathryn G Roberts, Charles G Mullighan, Hagop M Kantarjian, Nitin Jain
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO precision oncology 7 (2023)
Hussein A Abbas, Edward Ayoub, Hanxiao Sun, Rashmi Kanagal-Shamana, Nicholas James Short, Ghayas C Issa, Musa Ylimaz, Sherry Pierce, Daniel Rivera, Brent Cham, Shane Wing, Ziyi Li, Danielle Hammond, Elias Jabbour, Gautam Borthakur, Guillermo Garcia-Manero, Michael Andreeff, Naval G Daver, Tapan Kadia, Marina Konopleva, Courtney D D DiNardo, Farhad Ravandi
Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of TP53 alterations and venetoclax treatment. Leukemia & lymphoma (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Jayastu Senapati, Mahran Shoukier, Guillermo Garcia Manero, Xuemei Wang, Keyur Patel, Tapan Mahendra Kadia, Farhad Ravandi, Naveen Pemmaraju, Maro Ohanian DO, Naval G Daver, Courtney D D DiNardo, Yesid Alvarado, Jeffrey Aldrich, Gautam Borthakur
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia. American journal of hematology 97 (5) (2022)
Gautam Borthakur, Farhad Ravandi, Keyur Patel, Xuemei Wang, Tapan Mahendra Kadia, Courtney D D DiNardo, Guillermo Garcia Manero, Naveen Pemmaraju, Elias J Jabbour, Koichi Takahashi, Maro Ohanian DO, Naval G Daver, Yesid Alvarado, Mark Brandt, Sherry Pierce, Hagop M Kantarjian
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients. American journal of hematology 97 (11) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology (2022)
Sangeetha Venugopal, Courtney D D DiNardo, Sanam Loghavi, Wei Qiao, Farhad Ravandi, Marina Y Konopleva, Tapan Mahendra Kadia, Kapil N Bhalla, Elias J Jabbour, Ghayas C Issa, Walid Macaron, Naval G Daver, Gautam Borthakur, Guillermo Montalban Bravo, Musa Ylimaz, Keyur P Patel, Rashmi Kanagal-Shamana, Kelly Sharon Chien, Abhishek Maiti, Hagop M Kantarjian, Nicholas James Short
Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia. American journal of hematology 97 (12) (2022)
Daniel Rivera, Kunhwa Kim, Rashmi Kanagal-Shamana, Gautam Borthakur, Guillermo Montalban Bravo, Naval G Daver, Courtney D D DiNardo, Nicholas James Short, Musa Ylimaz, Naveen Pemmaraju, Koichi Takahashi, Elias J Jabbour, Sherry Pierce, Marina Y Konopleva, Kapil N Bhalla, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes. American journal of hematology 97 (12) (2022)
Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Courtney D Dinardo, Tapan M Kadia, Elias Jabbour, Marina Konopleva, Walid Macaron, Jing Ning, Junsheng Ma, Sherry Pierce, Yesid Alvarado, Koiji Sasaki, Koichi Takahashi, Zeev E Estrov, Lucia Masarova, Ghayas C Issa, Guillermo Montalban-Bravo, Michael Andreeff, Jan A Burger, Darla Miller, Lynette Alexander, Aung Naing, Guillermo Garcia-Manero, Farhad Ravandi, Naval Daver
A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma 63 (9) (2022)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Jeffrey Skinner, Sara Dellasala, Musa Ylimaz, Alessandra Ferrajoli, Prithviraj Bose, Philip Thompson, Yesid Alvarado, Nitin Jain, Guillermo Garcia Manero, Koichi Takahashi, Gautam Borthakur, Naveen Pemmaraju, Sherry Pierce, Hagop M Kantarjian
Low-dose dasatinib 50 mg/day versus standard-dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis. American journal of hematology 97 (11) (2022)
Mark A Dawson, Gautam Borthakur, Brian James Patrick Huntly, Anastasios Karadimitris, Adrian Alegre, Aristeidis Chaidos, Dan T Vogl, Daniel A Pollyea, Faith E Davies, Gareth J Morgan, Jacob Lowell Glass, Manali Kamdar, Maria-Victoria Mateos-Manteca, Natalia Tovar, Paul Yeh, Regina García Delgado, Faisal Basheer, Ludovica Marando, Paolo Gallipoli, Anastasia Wyce, Anu Shilpa Krishnatry, Olena Barbash, Evi Bakirtzi, Geraldine Ferron-Brady, Natalie O Karpinich, Michael T McCabe, Shawn W Foley, Thierry Horner, Arindam Dhar, Brandon E Kremer, Michael J Dickinson
A phase I/II open-label study of molibresib for the treatment of relapsed/refractory hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Tapan Mahendra Kadia, Patrick K Reville, Xuemei Wang, Caitlin R Rausch, Gautam Borthakur, Naveen Pemmaraju, Naval G Daver, Courtney D DiNardo, Koiji Sasaki, Ghayas C Issa, Maro Ohanian DO, Guillermo Montalban-Bravo, Nicholas James Short, Nitin Jain, Alessandra Ferrajoli, Kapil N Bhalla, Elias J Jabbour, Koichi Takahashi, Rashmi Malla, Kelly Quagliato, Rashmi Kanagal-Shamana, Sairah A Ahmed, Michael Andreeff, Guillermo Garcia Manero, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (33) (2022)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Joseph D Khoury, Sergej Konoplev, Sanam Loghavi, Keyur Patel, Guillermo Montalban Bravo, Lucia Masarova, Marina Y Konopleva, Hagop Kantarjian
Prediction of survival with intensive chemotherapy in acute myeloid leukemia. American journal of hematology 97 (7) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Sangeetha Venugopal, Koichi Takahashi, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Sanam Loghavi, Nicholas James Short, Maro Ohanian, Lucia Masarova, Ghayas C Issa, Xuemei Wang, Bueso-Ramos Carlos, Musa Ylimaz, Tapan Mahendra Kadia, Michael Andreeff, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian, Courtney D D DiNardo
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy. Blood cancer journal 12 (1) (2022)
Curtis A Lachowiez, Patrick K Reville, Hagop M Kantarjian, Elias J Jabbour, Gautam Borthakur, Naval G Daver, Ghayas C Issa, Ken Furudate, Tomoyuki Tanaka, Sherry Pierce, Guillin Tang, Keyur P Patel, Jeffrey Medeiros, Hussein A Abbas, Fady Gh Haddad, Daniel Hammond, Nicholas James Short, Abhishek Maiti, Musa Ylimaz, Koiji Sasaki, Koichi Takahashi, Naveen Pemmaraju, Marina Y Konopleva, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Sanam Loghavi, Courtney D D DiNardo
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. American journal of hematology 97 (11) (2022)
Kunhwa Kim, Marina Y Konopleva, Courtney D D DiNardo, Gautam Borthakur, Sanam Loghavi, Guillin Tang, Naval G Daver, Naveen Pemmaraju, Elias J Jabbour, Caitlin R Rausch, Musa Ylimaz, Koiji Sasaki, Nicholas James Short, Nitin Jain, Mark Brandt, Sherry Pierce, Guillermo Garcia Manero, Farhad Ravandi, Hagop Kantarjian, Tapan Mahendra Kadia
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. American journal of hematology 97 (7) (2022)
Musa Ylimaz, Hagop M Kantarjian, Nicholas James Short, Patrick K Reville, Marina Y Konopleva, Tapan Mahendra Kadia, Courtney D D DiNardo, Gautam Borthakur, Naveen Pemmaraju, Abhishek Maiti, Elias J Jabbour, Nitin Jain, Ghayas C Issa, Koichi Takahashi, Koiji Sasaki, Maro Ohanian, Sherry Pierce, Guillin Tang, Sanam Loghavi, Keyur Pravinchandra Patel, Sa A Wang, Guillermo Garcia Manero, Michael Andreeff, Farhad Ravandi, Naval G Daver
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML. Blood cancer journal 12 (5) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Courtney D D DiNardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Tapan Mahendra Kadia, Naval G Daver, Lianchun Xiao, Maria Adeoti, Nicholas James Short, Koji Sasaki, Sa A Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Ylimaz, Nitin Jain, Michael Andreeff, Guillermo Garcia Manero, Steven Kornblau, Farhad Ravandi, Elias J Jabbour, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia. American journal of hematology 97 (8) (2022)
Sujan Piya, Yaling Yang, Seemana Bhattacharya, Priyanka Sharma, Huaxian Ma, Hong Mu, Hua He, Vivian Ruvolo, Natalia Baran, Richard Eric Davis, Abhinav K Jain, Marina Y Konopleva, Hagop M Kantarjian, Michael Andreeff, Mingjian James You, Gautam Borthakur
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL. Leukemia 36 (5) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Warren C Fiskus, Taghi Manshouri, Christine Birdwell, Christopher P Mill, Lucia Masarova, Prithviraj Bose, Tapan Mahendra Kadia, Naval G Daver, Courtney D D DiNardo, Gautam Borthakur, Joseph D Khoury, Srdan Verstovsek, Kapil N Bhalla
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells. Blood cancer journal 12 (1) (2022)
Patrick K Reville, Koiji Sasaki, Hagop M Kantarjian, Naval G Daver, Musa Ylimaz, Courtney D D DiNardo, Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Rohtesh S Mehta, Sherry Pierce, Sergej N Konoplev, Joseph D Khoury, Guillermo Garcia Manero, Marina Y Konopleva, Elias Jabbour, Farhad Ravandi, Tapan Mahendra Kadia
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. American journal of hematology 97 (3) (2022)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Jorge E Cortes, Marina Y Konopleva, Naveen Pemmaraju, Yesid Alvarado, Musa Ylimaz, Gautam Borthakur, Courtney D D DiNardo, Nitin Jain, Naval G Daver, Nicholas James Short, Elias J Jabbour, Hagop Kantarjian
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors. American journal of hematology 97 (7) (2022)
Ghayas C Issa, Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning, Nicholas James Short, Fadi Haddad, Zhenya Tang, Keyur Pravinchandra Patel, Branko Cuglievan, Naval G Daver, Courtney D D DiNardo, Elias J Jabbour, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Marina Y Konopleva, Michael Andreeff, Hagop M Kantarjian, Farhad Ravandi
Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements. Blood cancer journal 11 (9) (2021)
Warren C Fiskus, Christopher P Mill, Behnam Nabet, Dimuthu Perera, Christine Birdwell, Taghi Manshouri, Bernardo Lara, Tapan Mahendra Kadia, Courtney D D DiNardo, Koichi Takahashi, Naval G Daver, Prithviraj Bose, Lucia Masarova, Naveen Pemmaraju, Steven Mitchell Kornblau, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Sunil Sharma, Matthew Stubbs, Xiaoping Su, Michael R Green, Cristian Coarfa, Srdan Verstovsek, Joseph D Khoury, Christopher R Vakoc, Kapil N Bhalla
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells. Blood cancer journal 11 (5) (2021)
Rashmi Kanagal-Shamana, Guillermo Montalban-Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A Class, Elias Jabbour, David A Sallman, Anthony Michael Hunter, Christopher Benton, Kelly S Chien, Rajyalakshmi Luthra, Carlos E Bueso-Ramos, Tapan Mahendra Kadia, Michael Andreeff, Rami S Komrokji, Najla H Al Ali, Nicholas James Short, Naval G Daver, Mark J Routbort, Joseph D Khoury, Keyur Pravinchandra Patel, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, Kelly A Soltysiak, Olivier Lichtarge, L Jeffrey Medeiros, Hagop M Kantarjian, Guillermo Garcia Manero
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis. Blood cancer journal 11 (3) (2021)
Patrick K Reville, Hagop M Kantarjian, Farhad Ravandi, Elias Jabbour, Courtney D D DiNardo, Naval Daver, Naveen Pemmaraju, Maro Ohanian, Yesid Alvarado, Lianchun Xiao, Gheath Alatrash, Sanam Loghavi, Caitlin R Rausch, Gautam Borthakur, Marina Y Konopleva, Jorge E Cortes, Tapan Mahendra Kadia
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study. Blood cancer journal 11 (3) (2021)
Gail J Roboz, Karen Yee, Amit Verma, Gautam Borthakur, Adolfo de la Fuente Burguera, Guillermo Sanz, Helai P Mohammad, Ryan G Kruger, Natalie O Karpinich, Geraldine Ferron-Brady, Andre Acusta, Heather Del Buono, Therese Collingwood, Marc Ballas, Arindam Dhar, Andrew H Wei
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes. Leukemia & lymphoma 63 (2) (2021)
Courtney D D DiNardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Lianchun Xiao, Tapan Mahendra Kadia, Naval G Daver, Maria Adeoti, Nicholas James Short, Koiji Sasaki, Sa Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Yilmaz, Nitin Jain, Michael Andreeff, Elias J Jabbour, Guillermo Garcia Manero, Steven Mitchell Kornblau, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (25) (2021)
Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Gautam Borthakur, Elias Jabbour, Guillermo Garcia Manero, Marina Y Konopleva, Farhad Ravandi
Acute myeloid leukemia: current progress and future directions. Blood cancer journal 11 (2) (2021)
Hussein A Abbas, Patrick K Reville, Alexis Geppner, Caitlin R Rausch, Naveen Pemmaraju, Maro Ohanian, Koji Sasaki, Gautam Borthakur, Naval Daver, Courtney DiNardo, Carlos Bueso-Ramos, Sherry Pierce, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian, Tapan M Kadia
Clinical and molecular characterization of myeloid sarcoma without medullary leukemia. Leukemia & lymphoma (2021)
Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Marina Y Konopleva, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Rashmi Kanagal-Shamana, Xuemei Wang, Xuelin Huang, Sherry Pierce, Caitlin R Rausch, Jan Burger, Alessandra Ferrajoli, Nitin Jain, Uday Popat, Zeev Estrov, Srdan Verstovsek, Elias J Jabbour, Guillermo Garcia Manero, Hagop Kantarjian
Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia. American journal of hematology 96 (8) (2021)
Gautam Borthakur, Hagop M Kantarjian
Core binding factor acute myelogenous leukemia-2021 treatment algorithm. Blood cancer journal 11 (6) (2021)
Guillermo Montalban-Bravo, Danielle Hammond, Courtney D D DiNardo, Marina Y Konopleva, Gautam Borthakur, Nicholas James Short, Jorge Ramos-Perez, Veronica Guerra, Rashmi Kanagal-Shamana, Kiran Naqvi, Koiji Sasaki, Elias Jabbour, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval Daver, Zeev Estrov, Sherry Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Activity of venetoclax-based therapy in chronic myelomonocytic leukemia. Leukemia 35 (5) (2021)
Kelly Sharon Chien, Kunhwa Kim, Graciela M Nogueras-Gonzalez, Gautam Borthakur, Kiran Naqvi, Naval G Daver, Guillermo Montalban Bravo, Jorge E Cortes, Courtney D DiNardo, Elias Jabbour, Yesid Alvarado, Michael Andreeff, Prithviraj Bose, Nitin Jain, Tapan M Kadia, Xuelin Huang, Kimberly B Sheppard, Cheri Klingner-Winton, Sherry A Pierce, Xiao Qin Dong, Kelly A Soltysiak, Hagop M Kantarjian, Guillermo Garcia Manero
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome. British journal of haematology 195 (3) (2021)
Abhishek Maiti, Courtney D D DiNardo, Naval G Daver, Caitlin R Rausch, Farhad Ravandi, Tapan Mahendra Kadia, Naveen Pemmaraju, Gautam Borthakur, Prithviraj Bose, Ghayas C Issa, Nicholas James Short, Musa Yilmaz, Guillermo Montalban-Bravo, Alessandra Ferrajoli, Elias J Jabbour, Nitin Jain, Maro Ohanian, Koichi Takahashi, Phillip A Thompson, Sanam Loghavi, Kathryn S Montalbano, Sherry Pierce, William G Wierda, Hagop M Kantarjian, Marina Y Konopleva
Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia. Blood cancer journal 11 (2) (2021)
Koiji Sasaki, Tapan Mahendra Kadia, Kebede H Begna, Courtney D D DiNardo, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Guillermo Montalban Bravo, Lucia Masarova, Sherry Pierce, Marina Y Konopleva, Farhad Ravandi, Ayalew Tefferi, Hagop Kantarjian
Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy. American journal of hematology (2021)
Nitin Jain, Phillip A Thompson, Jan A Burger, Alessandra Ferrajoli, Koichi Takahashi, Zeev E Estrov, Gautam Borthakur, Prithviraj Bose, Tapan Mahendra Kadia, Naveen Pemmaraju, Koiji Sasaki, Marina Y Konopleva, Elias J Jabbour, Naveen Garg, Xuemei Wang, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Wei Wang, Jeffrey Jorgensen, Sa Wang, Wanda Lopez, Ana Ayala, William Plunkett, Varsha Gandhi, Hagop M Kantarjian, Susan O'Brien, Michael Keating, William G Wierda
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia 35 (12) (2021)
Jorge M Ramos Perez, Keyur P Patel, Sanam Loghavi, Guillermo Garcia-Manero, Gautam Borthakur, Elias Jabbour, William Wierda, Sherry Pierce, Mark Brandt, Steven Kornblau, Tapan Kadia, Naval Daver, Courtney D DiNardo, Nitin Jain, Musa Yilmaz, Nicholas Short, Srdan Verstovsek, Alessandra Ferrajoli, Michael Andreeff, Marina Konopleva, Daniel Rivera, David McCue, Hagop M Kantarjian, Farhad Ravandi
Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Leukemia & lymphoma (2021)
Abhishek Maiti, Wei Qiao, Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Elias J Jabbour, Naval G Daver, Gautam Borthakur, Guillermo Garcia Manero, Sherry A Pierce, Kathryn S Montalbano, Naveen Pemmaraju, Kiran Naqvi, Maro Ohanian DO, Nicholas James Short, Yesid Alvarado, Koichi Takahashi, Musa Ylimaz, Nitin Jain, Steven M Kornblau, Michael Andreeff, Prithviraj Bose, Alessandra Ferrajoli, Ghayas C Issa, Lucia Masarova, Philip A Thompson, Caitlin R Rausch, Jing Ning, Hagop M Kantarjian, Courtney D D DiNardo, Marina Y Konopleva
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality. American journal of hematology 96 (3) (2020)
Koiji Sasaki, Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Elias J Jabbour, Farhad Ravandi, Tapan Mahendra Kadia, Naval G Daver, Naveen Pemmaraju, Marina Y Konopleva, Gautam Borthakur, Koichi Takahashi, Keyur Patel, Kelly A Soltysiak, Kelly Sharon Chien, Kenichi Sakurai, Sherry Pierce, Hagop M Kantarjian, Guillermo Garcia-Manero
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3). American journal of hematology 95 (12) (2020)
Celalettin Ustun, Elizabeth A Morgan, Ethan M Ritz, Hanne Vestergaard, Sheeja Pullarkat, Philip M Kluin, Robert Ohgami, Linda B Baughn, Young Kim, Nam K Ku, David Czuchlewski, Michael Boe Møller, Ana-Iris Schiefer, Krzysztof Mrózek, Hans-Peter Horny, Tracy I George, Thomas Kielsgaard Kristensen, Todd Beck, Sunita Nathan, Cecilia Arana Yi, Cecilia Yeung, Vinod A Pullarkat, Jason Gotlib, Cem Akin, Jessica Kohlschmidt, Amandeep Salhotra, Lorinda Soma, Dong Chen, Se Y Han, Christina Cho, Wolfgang R Sperr, Sigurd Broesby-Olsen, Michael A Linden, Michelle Dolan, Gregor Hoermann, Jason L Hornick, Clara Bloomfield, Ryo Nakamura, H Joachim Deeg, Mark R Litzow, Gautam Borthakur, Daniel Weisdorf, Gerwin Huls, Miguel-Angel Perales, Peter Valent, Guido Marcucci
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure. International journal of laboratory hematology 43 (1) (2020)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Veronica Guerra, Jorge Ramos-Perez, Danielle Hammond, Paul Shilpa, Kiran Naqvi, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Marina Y Konopleva, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Zeev Estrov, Joseph D Khoury, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Keyur Patel, Hagop M Kantarjian, Guillermo Garcia Manero
Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia. American journal of hematology 96 (2) (2020)
Natalie Cheng Chen, Gautam Borthakur, Naveen Pemmaraju
Bromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasms. Leukemia & lymphoma 62 (3) (2020)
Heesun Joyce Rogers, Xiaoqiong Wang, Yan Xie, Adam R Davis, Beenu Thakral, Sa A Wang, Gautam Borthakur, Miguel D Cantu, Elizabeth M Margolskee, John K S Philip, Madina Sukhanova, Adam Bagg, Carlos E Bueso-Ramos, Attilio Orazi, Daniel A Arber, Eric D Hsi, Robert P Hasserjian
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. American journal of hematology 95 (7) (2020)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Caleb A Class, Koji Sasaki, Farhad Ravandi, Jorge E Cortes, Naval G Daver, Koichi Takahashi, Nicholas James Short, Courtney D D DiNardo, Elias J Jabbour, Gautam Borthakur, Kiran Naqvi, Ghayas C Issa, Marina Y Konopleva, Joseph D Khoury, Mark Routbort, Sherry Pierce, Kim-Anh Do, Carlos Bueso-Ramos, Keyur Patel, Hagop M Kantarjian, Guillermo Garcia-Manero, Tapan Mahendra Kadia
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy. American journal of hematology 95 (6) (2020)
Catherine Kendall Major, Hagop Kantarjian, Koji Sasaki, Gautam Borthakur, Tapan Kadia, Naveen Pemmaraju, Courtney DiNardo, Nicholas J Short, Naval Daver, Elias Jabbour, Richard Champlin, Guillermo Garcia-Manero, Marina Konopleva, Michael Andreeff, Steven Kornblau, William Wierda, Sherry Pierce, Farhad Ravandi, Jorge E Cortes
Survivorship in AML - a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years. Leukemia & lymphoma 61 (13) (2020)

Gautam Borthakur.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gautam Borthakur